Advertisement
Advertisement

TYRA

TYRA logo

Tyra Biosciences, Inc. Common Stock

30.37
USD
Sponsored
+0.31
+1.03%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

30.37

0.00
0.00%

Tyra Biosciences, Inc. Common Stock Profile

About

Tyra Biosciences Inc. is a precision oncology company. It focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. The company's lead product candidate includes TYRA-300. Tyra Biosciences Inc. is based in CARLSBAD, Calif.

Info & Links

CEO

Todd Harris

Headquarters

2656 STATE STREET
CARLSBAD, CA 92008, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.tyra.bio

Auditor

Ernst & Young LLP

Share holders

21

Employees

87

Tyra Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.81B

Enterprise Value

1.72B

Enterprise Value/EBITDA(ttm)

-12.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

7.56

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-41.17%

Return on Invested Capital(ttm)

-41.70%

Return on Assets(ttm)

-38.40%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-142.37M

Net Income Available to Common(ttm)

-131.11M

Diluted EPS(ttm)

-2.01

Share Statistics

Beta (5Y Monthly)

0.96

52-Week Change

212.77%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

59.47M

Dividend Yield

0.00%

Float4

45.68M

% Held by Insiders

15.20%

% Held by Institutions

84.14%

Balance Sheet

Total Cash(mrq)

383.47M

Total Cash Per Share(mrq)

6.45

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.67%

Quick Ratio(mrq)

14.67%

Book Value Per Share(mrq)

4.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.60

Free Cash Flow(ytd)

-95.28M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement